Now Available: Final Rule for FDAAA 801 and NIH Policy on Clinical Trial Reporting
24 studies found for:    " March 31, 2010":" April 30, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Show Display Options
RSS Create an RSS feed from your search for:
" March 31, 2010":" April 30, 2010"[FIRST-RECEIVED-DATE]AND HIV[CONDITION]
Need help? See RSS Feeds
Choose a feed type:
Show studies first received on any dateShow studies that were first received in the last 14 days
Show studies last updated date on any dateShow studies that were added or modified in the last 14 days
Rank Status Study
1 Active, not recruiting
Has Results
PRINCE: Study of Atazanavir (ATV)/Ritonavir (RTV)
Condition: HIV Infections
Interventions: Drug: Atazanavir powder;   Drug: Ritonavir oral solution;   Drug: Atazanavir capsules;   Drug: Ritonavir capsules
2 Active, not recruiting Evaluating the Safety and Immune Response of an Adenovirus-Based HIV Vaccine in HIV-Uninfected Adults
Condition: HIV Infections
Interventions: Biological: Ad26.ENVA.01 (rAd26);   Biological: Placebo Vaccine
3 Completed
Has Results
Study to Evaluate the Safety and Efficacy of Stribild Versus Ritonavir-Boosted Atazanavir Plus Truvada in Human Immunodeficiency Virus, Type 1 (HIV-1) Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: Stribild;   Drug: ATV;   Drug: Ritonavir;   Drug: FTC/TDF;   Drug: Stribild Placebo;   Drug: ATV Placebo;   Drug: RTV Placebo;   Drug: FTC/TDF Placebo
4 Completed
Has Results
Safety and Efficacy of COBI-boosted Atazanavir Versus Ritonavir-boosted Atazanavir Each Administered With Emtricitabine/Tenofovir Disoproxil Fumarate in HIV-1 Infected, Antiretroviral Treatment-Naive Adults
Conditions: HIV;   HIV Infections
Interventions: Drug: COBI;   Drug: RTV;   Drug: ATV;   Drug: FTC/TDF;   Drug: COBI placebo;   Drug: RTV placebo
5 Completed
Has Results
H1N1 Influenza Vaccine Immunogenicity in HIV-1 Infected Patients
Condition: HIV Infections
Intervention: Biological: H1N1 vaccination
6 Completed Extended Follow-Up of Participants in Preventive HIV Vaccine Studies in Uganda
Condition: HIV Infections
Intervention:
7 Completed Test of an Intervention to Improve HIV Care
Condition: HIV Infection
Interventions: Behavioral: Patient Mentor Intervention;   Behavioral: HIV transmission risk reduction
8 Completed
Has Results
Heart Function in HIV-Negative Children Exposed to HIV and HAART
Condition: HIV Infections
Intervention:
9 Completed Project POWER, Adapting Project SAFE: Reducing STD/HIV Risk in Women Prisoners
Condition: HIV Infections
Interventions: Behavioral: Project POWER HIV Risk-reduction Intervention;   Behavioral: NC DOC Standard of Care for STIs
10 Unknown  Safety Study of Isentress® + Truvada® in Post-exposure Treatment of HIV Infection
Condition: HIV Infections
Interventions: Drug: raltegravir (Isentress);   Drug: Truvada®
11 Completed A Drug Interaction Study Evaluating GSK2248761 and Raltegravir Pharmacokinetics in Healthy Adult Subjects
Condition: HIV Infections
Interventions: Drug: Raltegravir;   Drug: GSK2248761;   Drug: GSK2248761 + Raltegravir
12 Recruiting Adherence to HIV Therapy in Heroin Addicts
Conditions: HIV;   Substance Abuse;   HIV Infections
Interventions: Drug: Oral Naltrexone (ON);   Drug: Implantable Naltrexone (IN)
13 Completed
Has Results
A Simplification Study of Unboosted Reyataz With Epzicom (ASSURE)
Condition: Infection, Human Immunodeficiency Virus
Interventions: Drug: Reyataz + Norvir + Truvada;   Drug: Reyataz + Epzicom
14 Unknown  A Trial to Test the Efficacy of a Tailored Intensive Smoking Cessation Intervention in Persons With HIV (PWHs)
Conditions: Smoking;   HIV Infections;   AIDS
Interventions: Behavioral: Positively Smoke Free;   Behavioral: Standard care
15 Completed HIV Physician's Survey
Condition: HIV
Intervention:
16 Completed PK of Tenofovir, Emtricitabine and Efavirenz in Healthy Volunteers
Conditions: HIV Infection;   HIV Infections
Intervention: Drug: Atripla®
17 Recruiting International HIV Antiretroviral Adherence, Resistance and Survival
Condition: HIV/AIDS
Intervention:
18 Completed HIV Risk Reduction in Subutex Injectors in Tbilisi
Condition: HIV
Interventions: Drug: methadone;   Drug: buprenorphine-naloxone (Suboxone) for 12 weeks
19 Unknown  Safety and Efficacy Study Comparing Raltegravir to a Protease Inhibitor in Treatment-naïve, HIV/Hepatitis C Drug Users
Conditions: HIV Infections;   Hepatitis C
Interventions: Drug: Raltegravir;   Drug: Atazanavir/Ritonavir
20 Completed Study to Compare the Virologic Efficacy in Cerebrospinal Fluid (CSF) and Neurocognitive State in Patients Infected by HIV-1 Long-term Treatment (> 3 Years) With Lopinavir / Ritonavir Monotherapy
Condition: HIV
Intervention: Procedure: Lumbar puncture

   Previous Page Studies Shown (1-20) Next Page (21-24) Show next page of results    Last Page
Study has passed its completion date and status has not been verified in more than two years.